This novel therapeutic approach utilizes specialized lipid nanoparticles (LNPs) to deliver follistatin messenger RNA (mRNA) directly to lung tumors, simultaneously inhibiting cancer growth and reversing cachexia, a severe muscle-wasting syndrome.
#Oncology #Pharmacology #Nanomedicine #MolecularGenetics #cancer #sflorg
https://www.sflorg.com/2026/04/ongy04062601.html
#Oncology #Pharmacology #Nanomedicine #MolecularGenetics #cancer #sflorg
https://www.sflorg.com/2026/04/ongy04062601.html
